{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T09:53:01Z","timestamp":1760953981650},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2014,12,29]],"date-time":"2014-12-29T00:00:00Z","timestamp":1419811200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0115713","type":"journal-article","created":{"date-parts":[[2014,12,29]],"date-time":"2014-12-29T18:52:51Z","timestamp":1419879171000},"page":"e115713","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Adjuvant Effects Elicited by Novel Oligosaccharide Variants of Detoxified Meningococcal Lipopolysaccharides on Neisseria meningitidis Recombinant PorA Protein: A Comparison in Mice"],"prefix":"10.1371","volume":"9","author":[{"given":"Ojas H.","family":"Mehta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunnstein","family":"Norheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J . Claire","family":"Hoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine S.","family":"Rollier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry C.","family":"Nagaputra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Makepeace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J. P.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manish","family":"Sadarangani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek W.","family":"Hood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Feavers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy P.","family":"Derrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E . Richard","family":"Moxon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,12,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S1473-3099(13)70341-4","article-title":"A vaccine against serogroup B Neisseria meningitidis: dealing with uncertainty","volume":"14","author":"SM Andrews","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1586\/erv.09.30","article-title":"Challenges and progress in the development of a serogroup B meningococcal vaccine","volume":"8","author":"S Lewis","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4161\/hv.4513","article-title":"Strategies for development of universal vaccines against meningococcal serogroup B disease: the most promising options and the challenges evaluating them","volume":"3","author":"J Holst","year":"2007","journal-title":"Human vaccines"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/jama.281.16.1520","article-title":"Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile","volume":"281","author":"JW Tappero","year":"1999","journal-title":"JAMA: the journal of the American Medical Association"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.4161\/hv.24129","article-title":"Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): lessons from past programs and implications for the future","volume":"9","author":"J Holst","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1128\/IAI.73.7.4070-4080.2005","article-title":"Characterization of native outer membrane vesicles from lpxL mutant strains of Neisseria meningitidis for use in parenteral vaccination","volume":"73","author":"M Fisseha","year":"2005","journal-title":"Infection and immunity"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.vaccine.2010.12.039","article-title":"A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression","volume":"29","author":"PB Keiser","year":"2011","journal-title":"Vaccine"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Wright JC, Plested J, Moxon ER (2006) Genetics, Structure and Function of Lipopolysaccharide. In: Frosch M, Maiden, MC, editor. Handbook of Meningococcal Disease: WILEY-VCH.","DOI":"10.1002\/3527608508.ch9"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.1128\/IAI.69.10.5981-5990.2001","article-title":"Modification of lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity, and adjuvant activity","volume":"69","author":"P van der Ley","year":"2001","journal-title":"Infection and immunity"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"5091","DOI":"10.1016\/j.vaccine.2005.06.001","article-title":"Well-defined and potent liposomal meningococcal B vaccines adjuvated with LPS derivatives","volume":"23","author":"C Arigita","year":"2005","journal-title":"Vaccine"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/meth.1999.0834","article-title":"Monophosphoryl lipid A (MPL) formulations for the next generation of vaccines","volume":"19","author":"JR Baldridge","year":"1999","journal-title":"Methods"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.vaccine.2008.11.046","article-title":"Incorporation of LpxL1, a detoxified lipopolysaccharide adjuvant, in influenza H5N1 virosomes increases vaccine immunogenicity","volume":"27","author":"JJ de Vries","year":"2009","journal-title":"Vaccine"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"5939","DOI":"10.1128\/IAI.00846-07","article-title":"Agonists of Toll-like receptors 3, 4, 7, and 9 are candidates for use as adjuvants in an outer membrane vaccine against Neisseria meningitidis serogroup B","volume":"75","author":"F Fransen","year":"2007","journal-title":"Infection and immunity"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1128\/CVI.00561-13","article-title":"Neisseria meningitidis native outer membrane vesicles containing different lipopolysaccharide glycoforms as adjuvants for meningococcal and nonmeningococcal antigens","volume":"21","author":"JC Nagaputra","year":"2014","journal-title":"Clinical and vaccine immunology: CVI"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1128\/JB.187.5.1710-1715.2005","article-title":"The core lipopolysaccharide of Escherichia coli is a ligand for the dendritic-cell-specific intercellular adhesion molecule nonintegrin CD209 receptor","volume":"187","author":"J Klena","year":"2005","journal-title":"Journal of bacteriology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1462-5822.2005.00623.x","article-title":"Neisseria meningitidis expressing lgtB lipopolysaccharide targets DC-SIGN and modulates dendritic cell function","volume":"8","author":"L Steeghs","year":"2006","journal-title":"Cellular Microbiology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1365-2958.1995.mmi_18040729.x","article-title":"Molecular analysis of a locus for the biosynthesis and phase-variable expression of the lacto-N-neotetraose terminal lipopolysaccharide structure in Neisseria meningitidis","volume":"18","author":"MP Jennings","year":"1995","journal-title":"Mol Microbiol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0378-1097(96)00484-3","article-title":"Analysis of the icsBA locus required for biosynthesis of the inner core region from Neisseria meningitidis lipopolysaccharide","volume":"146","author":"P van der Ley","year":"1997","journal-title":"FEMS microbiology letters"},{"key":"ref19","first-page":"67","article-title":"Production, characterization and control of MenB-vaccine \u201cFolkehelsa\u201d: an outer membrane vesicle vaccine against group B meningococcal disease","volume":"14","author":"JH Fredriksen","year":"1991","journal-title":"NIPH annals"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"6970","DOI":"10.1128\/JB.186.20.6970-6982.2004","article-title":"lpt6, a gene required for addition of phosphoethanolamine to inner-core lipopolysaccharide of Neisseria meningitidis and Haemophilus influenzae","volume":"186","author":"JC Wright","year":"2004","journal-title":"J Bacteriol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0022-1759(90)90018-Q","article-title":"Increased resolution of lipopolysaccharides and lipooligosaccharides utilizing tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis","volume":"126","author":"AJ Lesse","year":"1990","journal-title":"J Immunol Methods"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-1-61779-346-2_6","article-title":"Expression, purification, and crystallization of neisserial outer membrane proteins","volume":"799","author":"M Saleem","year":"2012","journal-title":"Methods in molecular biology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0003-2697(77)90043-4","article-title":"A simplification of the protein assay method of Lowry et al. which is more generally applicable","volume":"83","author":"GL Peterson","year":"1977","journal-title":"Anal Biochem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1128\/IAI.01338-10","article-title":"Potential of recombinant opa proteins as vaccine candidates against hyperinvasive meningococci","volume":"79","author":"MJ Callaghan","year":"2011","journal-title":"Infection and immunity"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1128\/CVI.00342-09","article-title":"Evaluation of a whole-blood cytokine release assay for use in measuring endotoxin activity of group B Neisseria meningitidis vaccines made from lipid A acylation mutants","volume":"17","author":"MB Stoddard","year":"2010","journal-title":"Clinical and vaccine immunology: CVI"},{"key":"ref26","first-page":"255","article-title":"Determination of antibody responses to meningococcal antigens by ELISA","volume":"66","author":"E Rosenqvist","year":"2001","journal-title":"Methods in molecular medicine"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1128\/JCM.29.7.1439-1446.1991","article-title":"Comparisons of standard curve-fitting methods to quantitate Neisseria meningitidis group A polysaccharide antibody levels by enzyme-linked immunosorbent assay","volume":"29","author":"BD Plikaytis","year":"1991","journal-title":"J Clin Microbiol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1128\/IAI.62.7.2984-2990.1994","article-title":"Immune responses in humans and animals to meningococcal transferrin-binding proteins: implications for vaccine design","volume":"62","author":"DA Ala'Aldeen","year":"1994","journal-title":"Infect Immun"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Borrow R, Carlone GM (2001) Serogroups B and C serum bactericidal assays. In: Pollard AJ, Maiden MC, editors. Meningococcal Vaccines: Methods and Protocols. Totowa: Humana Press.","DOI":"10.1385\/1-59259-148-5:289"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1086\/338269","article-title":"Complement activation induced by purified Neisseria meningitidis lipopolysaccharide (LPS), outer membrane vesicles, whole bacteria, and an LPS-free mutant","volume":"185","author":"A Bjerre","year":"2002","journal-title":"The Journal of infectious diseases"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0264-410X(02)00546-7","article-title":"Restored functional immunogenicity of purified meningococcal PorA by incorporation into liposomes","volume":"21","author":"C Arigita","year":"2003","journal-title":"Vaccine"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1099\/00222615-43-5-335","article-title":"Antibodies to meningococcal class 1 outer-membrane protein and its variable regions in patients with systemic meningococcal disease","volume":"43","author":"I Idanpaan-Heikkila","year":"1995","journal-title":"J Med Microbiol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1084\/jem.171.6.1871","article-title":"Deduced amino acid sequences of class 1 protein (PorA) from three strains of Neisseria meningitidis. Synthetic peptides define the epitopes responsible for serosubtype specificity","volume":"171","author":"B McGuinness","year":"1990","journal-title":"J Exp Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1128\/IAI.00005-08","article-title":"Differential activation of human and mouse Toll-like receptor 4 by the adjuvant candidate LpxL1 of Neisseria meningitidis","volume":"76","author":"L Steeghs","year":"2008","journal-title":"Infection and immunity"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"5590","DOI":"10.1128\/IAI.71.10.5590-5597.2003","article-title":"Activation of human dendritic cells is modulated by components of the outer membranes of Neisseria meningitidis","volume":"71","author":"T Al-Bader","year":"2003","journal-title":"Infection and immunity"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1462-5822.2004.00392.x","article-title":"Activation of human dendritic cells by the PorA protein of Neisseria meningitidis","volume":"6","author":"T Al-Bader","year":"2004","journal-title":"Cellular Microbiology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2217\/fmb.10.41","article-title":"Innate immune function of the neisserial porins and the relationship to vaccine adjuvant activity","volume":"5","author":"LM Wetzler","year":"2010","journal-title":"Future Microbiol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri1391","article-title":"Toll-like receptor signalling","volume":"4","author":"S Akira","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"5688","DOI":"10.4049\/jimmunol.166.9.5688","article-title":"Endotoxin-induced maturation of MyD88-deficient dendritic cells","volume":"166","author":"T Kaisho","year":"2001","journal-title":"J Immunol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1126\/science.282.5396.2085","article-title":"Defective LPS signaling in C3H\/HeJ and C57BL\/10ScCr mice: mutations in Tlr4 gene","volume":"282","author":"A Poltorak","year":"1998","journal-title":"Science"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1074-7613(00)80119-3","article-title":"Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components","volume":"11","author":"O Takeuchi","year":"1999","journal-title":"Immunity"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1128\/IAI.01108-08","article-title":"Genetically modified L3,7 and L2 lipooligosaccharides from Neisseria meningitidis serogroup B confer a broad cross-bactericidal response","volume":"77","author":"V Weynants","year":"2009","journal-title":"Infection and immunity"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0161-5890(01)00067-0","article-title":"Molecular cloning of a C-type lectin superfamily protein differentially expressed by CD8alpha(-) splenic dendritic cells","volume":"38","author":"I Caminschi","year":"2001","journal-title":"Mol Immunol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1093\/intimm\/13.10.1283","article-title":"Five mouse homologues of the human dendritic cell C-type lectin, DC-SIGN","volume":"13","author":"CG Park","year":"2001","journal-title":"Int Immunol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.immuni.2007.03.012","article-title":"C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB","volume":"26","author":"SI Gringhuis","year":"2007","journal-title":"Immunity"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Svajger U, Anderluh M, Jeras M, Obermajer N (2010) C-type lectin DC-SIGN: An adhesion, signalling and antigen-uptake molecule that guides dendritic cells in immunity. Cell Signal.","DOI":"10.1016\/j.cellsig.2010.03.018"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/ni1112","article-title":"Toll-like receptor control of the adaptive immune responses","volume":"5","author":"A Iwasaki","year":"2004","journal-title":"Nat Immunol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1128\/IAI.55.11.2706-2714.1987","article-title":"Serological relationships between Escherichia coli and Salmonella smooth- and rough-mutant lipopolysaccharides as revealed by enzyme-linked immunosorbent assay for human immunoglobulin G antiendotoxin antibodies","volume":"55","author":"GR Barclay","year":"1987","journal-title":"Infection and immunity"},{"key":"ref49","first-page":"25","article-title":"Rough mutants of Salmonella typhimurium: immunochemical and structural analysis of lipopolysaccharides from rfaH mutants","volume":"116","author":"AA Lindberg","year":"1980","journal-title":"J Gen Microbiol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/intimm\/dxh264","article-title":"Association of SIGNR1 with TLR4-MD-2 enhances signal transduction by recognition of LPS in gram-negative bacteria","volume":"17","author":"K Nagaoka","year":"2005","journal-title":"Int Immunol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/glycob\/cwm057","article-title":"Human MD-2 discrimination of meningococcal lipid A structures and activation of TLR4","volume":"17","author":"SM Zimmer","year":"2007","journal-title":"Glycobiology"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0115713","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T12:48:27Z","timestamp":1598618907000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0115713"}},"subtitle":[],"editor":[{"given":"Daniela Flavia","family":"Hozbor","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,12,29]]},"references-count":51,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,12,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0115713","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,29]]}}}